Animal models of female sexual dysfunction: Basic considerations on drugs, arousal, motivation and behavior

被引:23
|
作者
Agmo, Anders [1 ]
机构
[1] Univ Tromso, Dept Psychol, N-9037 Tromso, Norway
关键词
Hypoactive sexual desire disorder; Sexual arousal disorder; Orgasmic disorder; Animal models; Neurotransmitters; Motivation; MEDIAL PREOPTIC AREA; OXYTOCIN RECEPTOR-BINDING; PREMENOPAUSAL WOMEN EFFICACY; INCENTIVE MOTIVATION; ESTROGEN-RECEPTOR; VENTROMEDIAL NUCLEUS; POSTMENOPAUSAL WOMEN; LORDOSIS BEHAVIOR; TIME-COURSE; MALE-RATS;
D O I
10.1016/j.pbb.2013.10.003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Female sexual dysfunctions are a heterogeneous group of symptoms with unknown but probably varying etiology. Social factors may contribute both to the prevalence and to the origin of these dysfunctions. The present review focuses on female hypoactive sexual desire disorder, sexual arousal disorder and orgasmic disorder. These disorders are generally the most common, according to epidemiological studies, and they can all be considered as disorders of motivation. An incentive motivational model of sexual behavior, applicable to humans as well as to non-human animals, is described and the dysfunctions placed into the context of this model. It is shown that endocrine alterations as well as observable alterations in neurotransmitter activity are unlikely causes of the disorders. A potential role of learning is stressed. Nevertheless, the role of some transmitters in female rodent sexual behavior is analyzed, and compared to data from women, whenever such data are available. The conclusion is that there is no direct coincidence between effects on rodent copulatory behavior and sexual behavior in women. Based on these and other considerations, it is suggested that sexual approach behaviors rather than copulatory reflexes in rodents might be of some relevance for human sexual behavior, and perhaps even for predicting the effects of interventions, perhaps even the effects of drugs. Female copulatory behaviors, including the proceptive behaviors, are less appropriate. The common sexual dysfunctions in women are not problems with the performance of copulatory acts, but with the desire for such acts, by feeling aroused by such acts and experiencing the pleasure expected to be caused by such acts. Finally, it is questioned whether female sexual dysfunctions are appropriate targets for pharmacological treatment. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 15
页数:13
相关论文
共 50 条
  • [1] Animal Model of Sexual Motivation and Arousal: Effects of Alcohol
    Angel Guevara, Miguel
    Rivera-Sanchez, Koral
    Hernandez-Gonzalez, Marisela
    Hernandez-Arteaga, Enrique
    Ramirez-Renteria, Mayra
    Sotelo-Tapia, Carolina
    ACTUALIDADES EN PSICOLOGIA, 2019, 33 (127): : 49 - 62
  • [2] Drugs for female sexual dysfunction
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1259): : 33 - 35
  • [4] SEXUAL-BEHAVIOR AND SEXUAL MOTIVATION IN FEMALE RAT
    DREWETT, RF
    NATURE, 1973, 242 (5398) : 476 - 477
  • [5] Hemodynamic evaluation of the female sexual arousal response in an animal model
    Min, K
    Munarriz, R
    Berman, J
    Kim, NN
    Goldstein, I
    Traish, AM
    Stankovic, MR
    JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) : 557 - 565
  • [6] Basic Science Mechanisms for Female Sexual Dysfunction
    Kim, Noel N.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 5 - 6
  • [7] An Integrative Theoretical Framework for Understanding Sexual Motivation, Arousal, and Behavior
    Toates, Frederick
    JOURNAL OF SEX RESEARCH, 2009, 46 (2-3) : 168 - 193
  • [8] DISSECTING MOTIVATION IN ANIMAL MODELS OF DOPAMINE DYSFUNCTION
    Simpson, Eleanor H.
    Ward, Ryan D.
    Kandel, Eric R.
    Balsam, Peter D.
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S40 - S40
  • [9] Designing drugs for the treatment of female sexual dysfunction
    Brown, Alan D.
    Blagg, Julian
    Reynolds, David S.
    DRUG DISCOVERY TODAY, 2007, 12 (17-18) : 757 - 766
  • [10] Female sexual response: The role of drugs in the management of sexual dysfunction
    Basson, R
    OBSTETRICS AND GYNECOLOGY, 2001, 98 (02): : 350 - 353